MENU
+Compare
MCK
Stock ticker: NYSE
AS OF
Apr 7, 12:58 PM (EDT)
Price
$659.93
Change
-$23.18 (-3.39%)
Capitalization
70.55B

MCK stock forecast, quote, news & analysis

McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers... Show more

MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for MCK with price predictions
Apr 01, 2025

Aroon Indicator for MCK shows an upward move is likely

MCK's Aroon Indicator triggered a bullish signal on April 01, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 263 similar instances where the Aroon Indicator showed a similar pattern. In of the 263 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MCK advanced for three days, in of 372 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for MCK turned negative on March 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MCK broke above its upper Bollinger Band on February 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. MCK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (7.608). P/E Ratio (24.254) is within average values for comparable stocks, (28.511). Projected Growth (PEG Ratio) (5.107) is also within normal values, averaging (4.521). Dividend Yield (0.004) settles around the average of (0.032) among similar stocks. P/S Ratio (0.241) is also within normal values, averaging (33.632).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

MCK paid dividends on April 01, 2025

McKesson Corp MCK Stock Dividends
А dividend of $0.71 per share was paid with a record date of April 01, 2025, and an ex-dividend date of March 03, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 9.87B. The market cap for tickers in the group ranges from 494.39K to 70.55B. MCK holds the highest valuation in this group at 70.55B. The lowest valued company is SNYR at 494.39K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was -5%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was -12%. EXHI experienced the highest price growth at 9%, while SNYR experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was -73% and the average quarterly volume growth was 18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 56
Price Growth Rating: 56
SMR Rating: 80
Profit Risk Rating: 79
Seasonality Score: 17 (-100 ... +100)
View a ticker or compare two or three
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a distributer of pharmaceuticals and provides healthcare software and health information technology services

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
6555 State Highway 161
Phone
+1 972 446-4800
Employees
51000
Web
https://www.mckesson.com